World-Renowned Care for Hematologic Malignancies

The Department of Hematology and Hematopoietic Cell Transplantation at City of Hope^® offers patients across Southern California access to advanced, multidisciplinary care for all types of hematologic cancers, as well as a wide range of non-cancerous blood disorders. City of Hope’s stem cell transplant program is the largest and one of the most successful in the United States, and we’ve been recognized among the nation’s top “Best Hospitals” for cancer for nearly two decades by U.S. News & World Report, which has also repeatedly rated us as “high performing” in leukemia, lymphoma and myeloma care.

City of Hope focuses on offering personalized care for hematologic disorders that combine comprehensive treatment with breakthrough therapies and access to innovative clinical trials. We also offer access to advanced options such as tumor profiling, immunotherapy, and bone marrow and stem cell transplantation. Our hematology department is led by dedicated clinical teams for every type of blood cancer, as well as nationally recognized experts in non-cancerous disorders like amyloidosis and myelodysplastic syndrome.

At City of Hope, our hematology experts collaborate to provide leading-edge care for every patient. In addition to a multidisciplinary approach in the clinic, many of our physicians are directly involved in translational research focused on developing new techniques and therapies to improve outcomes and quality of life for those with blood cancer or blood disorders. Patients who are referred to us benefit from many offerings, including those listed below.

• Access to our experts in the diagnosis and treatment of all hematologic malignancies at all stages, including:
  • All types of leukemia
  • Hodgkin and non-Hodgkin lymphoma
  • Myeloma
  • Amyloidosis
  • Myelodysplastic syndrome
  • Myeloproliferative neoplasm
• A multidisciplinary cancer care team that may include hematologist-oncologists, radiation oncologists, medical oncologists and supportive care specialists who have expertise in treating both adult and pediatric patients
• Our comprehensive molecular profiling options, which help care teams personalize the patient’s treatment plan
• Access to our hematopoietic cell transplantation program, which has performed more than 20,000 stem cell transplants. It is the largest and one of the most successful nationwide and has been a Core Clinical Center of the Blood & Marrow Transplant Clinical Trials Network^® since its inception in 2001
• Our cellular immunotherapy program, which offers access to leading-edge treatments such as bispecific antibody therapy and CAR T cell therapy, including outpatient care for certain patients receiving treatment at City of Hope Duarte
• Our pioneering approach to treating hematologic malignancies care, which brings together conventional treatments such as chemotherapy and radiation therapy with breakthrough options like immunotherapy and advanced treatments such as bone marrow and stem cell transplantation
• Access to an extensive clinical trials program for qualifying patients, offering greater access to the latest in blood cancer care
• The research expertise of the City of Hope’s Hematologic Research Institute, which conducts pioneering research in hematological malignancies